Interaction of letrozole and its degradation products with aromatase: chemometric assessment of kinetics and structure-based binding validation.

ABSTRACT: Letrozole is one of the most prescribed drugs for the treatment of breast cancer in post-menopausal women, and it is endowed with selective peripheral aromatase inhibitory activity. The efficacy of this drug is also a consequence of its long-lasting activity, likely due to its metabolic stability. The reactivity of cyano groups in the letrozole structure could, however, lead to chemical derivatives still endowed with residual biological activity. Herein, the chemical degradation process of the drug was studied by coupling multivariate curve resolution and spectrophotometric methodologies in order to assess a detailed kinetic profile. Three main derivatives were identified after drug exposure to different degradation conditions, consisting of acid-base and oxidative environments and stressi

SUBMITTER: De Luca M 

PROVIDER: S-EPMC9176668 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature